Group 4: Replacement therapy for adrenal insufficiency

被引：14
作者：
Castinetti, Frederic [1 ]
Guignat, Laurence [2 ]
Bouvattier, Claire [3 ]
Samara-Boustani, Dinane [4 ]
Reznik, Yves [5 ,6 ]
机构：
[1] Aix Marseille Univ, AP HM, Hop La Concept, Serv Endocrinol,CNRS,CRN2M,UMR7286, F-13005 Marseille, France
[2] CHU Paris Ctr, Hop Cochin, Serv Endocrinol & Malad Metab, F-75014 Paris, France
[3] Hop Bicetre, GHU Paris Sud, Serv Endocrinol Enfant, F-94270 Le Kremlin Bicetre, France
[4] CHU Paris, Hop Necker, Serv Endocrinol Gynecol & Diabetol Pediat, F-75015 Paris, France
[5] CHU Caen, Serv Endocrinol Diabete & Malad Metab, F-14032 Caen, France
[6] Univ Caen Normandie, F-14032 Caen, France
来源：
ANNALES D ENDOCRINOLOGIE | 2017年 / 78卷 / 06期
关键词：
Consensus; Addison's disease; Corticotropin deficiency; Adult; Children; Hydrocortisone; Fludrocortisone; DHEA; QUALITY-OF-LIFE; SUBCUTANEOUS HYDROCORTISONE INFUSION; MODIFIED-RELEASE HYDROCORTISONE; SUBJECTIVE HEALTH-STATUS; CORTISOL PRODUCTION-RATE; ADDISONS-DISEASE; GLUCOCORTICOID REPLACEMENT; 21-HYDROXYLASE DEFICIENCY; HYPOPITUITARY PATIENTS; PREMATURE MORTALITY;
D O I：
10.1016/j.ando.2017.10.007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：525 / 534
页数：10
相关论文
共 75 条
  • [41] Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women:: A placebo-controlled trial
    Johannsson, G
    Burman, P
    Wirén, L
    Engstróm, BE
    Nilsson, AG
    Ottosson, M
    Jonsson, B
    Bengtsson, BÅ
    Karlsson, FA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (05) : 2046 - 2052
  • [42] Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study
    Johannsson, Gudmundur
    Bergthorsdottir, Ragnhildur
    Nilsson, Anna G.
    Lennernas, Hans
    Hedner, Thomas
    Skrtic, Stanko
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2009, 161 (01) : 119 - 130
  • [43] Clinical implications for biochemical diagnostic thresholds of adrenal sufficiency using a highly specific cortisol immunoassay
    Kline, G. A.
    Buse, J.
    Krause, R. D.
    [J]. CLINICAL BIOCHEMISTRY, 2017, 50 (09) : 475 - 480
  • [44] Impaired health-related quality of life in Addison's disease - impact of replacement therapy, comorbidities and socio-economic factors
    Kluger, Nicolas
    Matikainen, Niina
    Sintonen, Harri
    Ranki, Annamari
    Roine, Risto P.
    Schalin-Jantti, Camilla
    [J]. CLINICAL ENDOCRINOLOGY, 2014, 81 (04) : 511 - 518
  • [45] CARDIAC-FAILURE IN ADDISONS-DISEASE
    KNOWLTON, AI
    BAER, L
    [J]. AMERICAN JOURNAL OF MEDICINE, 1983, 74 (05) : 829 - 836
  • [46] What is the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy?
    Lebbe, Marie
    Arlt, Wiebke
    [J]. CLINICAL ENDOCRINOLOGY, 2013, 78 (04) : 497 - 502
  • [47] CORTISOL PRODUCTION-RATE IN CHILDHOOD AND ADOLESCENCE
    LINDER, BL
    ESTEBAN, NV
    YERGEY, AL
    WINTERER, JC
    LORIAUX, DL
    CASSORLA, F
    [J]. JOURNAL OF PEDIATRICS, 1990, 117 (06) : 892 - 896
  • [48] The hypothalamic-pituitary-adrenal axis in pregnancy: Challenges in disease detection and treatment
    Lindsay, JR
    Nieman, LK
    [J]. ENDOCRINE REVIEWS, 2005, 26 (06) : 775 - 799
  • [49] Subjective health status in Norwegian patients with Addison's disease
    Lovås, K
    Loge, JH
    Husebye, ES
    [J]. CLINICAL ENDOCRINOLOGY, 2002, 56 (05) : 581 - 588
  • [50] Continuous subcutaneous hydrocortisone infusion in Addison's disease
    Lovas, Kristian
    Husebye, Eystein S.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 157 (01) : 109 - 112
12345678